Sporadic pregnancy loss and recurrent miscarriage.
Natural progesterone
Pregnancy loss
Recurrent miscarriage
Spontaneous abortion
Threatened miscarriage
Vaginal bleeding
Journal
Best practice & research. Clinical obstetrics & gynaecology
ISSN: 1532-1932
Titre abrégé: Best Pract Res Clin Obstet Gynaecol
Pays: Netherlands
ID NLM: 101121582
Informations de publication
Date de publication:
Nov 2020
Nov 2020
Historique:
received:
09
07
2020
revised:
16
08
2020
accepted:
01
09
2020
pubmed:
27
9
2020
medline:
25
11
2020
entrez:
26
9
2020
Statut:
ppublish
Résumé
Progesterone is essential for the maintenance of pregnancy, and progesterone deficiency is associated with miscarriage. The subject of whether progesterone supplementation in early pregnancy can prevent miscarriage has been a long-standing research question and has been investigated and debated in the medical literature for over 70 years. During this time, several different progestogens have been synthesised and tested for the prevention of miscarriage. In this chapter, we describe the prior evidence alongside the latest research using micronized natural progesterone as well as synthetic progestogens, which were used to treat both recurrent and threatened miscarriage. The totality of evidence indicates that women with a past history of miscarriage who present with bleeding in early pregnancy may benefit from the use of vaginal micronized progesterone. The clinical implications of the findings are discussed.
Identifiants
pubmed: 32978069
pii: S1521-6934(20)30141-3
doi: 10.1016/j.bpobgyn.2020.09.002
pii:
doi:
Substances chimiques
Progestins
0
Progesterone
4G7DS2Q64Y
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
30-39Informations de copyright
Copyright © 2020. Published by Elsevier Ltd.
Déclaration de conflit d'intérêts
Declaration of competing interest There are no conflicts of interest to report.